邱昭華(Chiu, Chao-Hua)　教授

Email
chaohuachiu@tmu.edu.tw
現   職
內科學科 教授
細胞治療與再生醫學國際博士學位 主任
臺北癌症中心 副院長

學經歷

學　歷

畢業學校與學位[修業時間]
臺北醫學大學醫學系 學士
1987/09~1994/06

本校學術經歷

任職單位與職稱[起迄時間]
內科學科教授
2023/05/05~

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
細胞治療與再生醫學國際博士學位主任
2024/08/01 ~
臺北癌症中心副院長
2022/06/02 ~

其它經歷

任職單位與職稱[起迄時間]
臺北癌症中心副院長
臺北醫學大學附設醫院醫師
臺北榮民總醫院醫師(退休)
1996/06~2022/06
員山榮民總醫院醫師
1994/06~1996/06

專長與研究領域

學門領域
胸腔內科
Chest
學術專長
Chest Medicine
Chest Medicine
Lung cancer research
Lung cancer research
臨床人體試驗
臨床人體試驗

論文著作

清冊下載

論文 Journal Paper


1. 2023 Chiang Chi Lu,Ho Hsiang Ling,Yeh Yi Chen,Lee Cheng Chia,Huang Hsu Ching,Shen Chia I.,Luo Yung Hung,Chen Yuh Min,Chiu Chao Hua,Chou Teh Ying,Chiang Chi Lu,Ho Hsiang Ling,Yeh Yi Chen,Lee Cheng Chia,Huang Hsu Ching,Shen Chia I.,Luo Yung Hung,Chen Yuh Min,Chiu Chao Hua,Chou Teh Ying. Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastases . Thoracic Cancer .2023 ;(14):1251-1259

2. 2023 Chiang Chi Lu,Ho Hsiang Ling,Yeh Yi Chen,Lee Cheng Chia,Huang Hsu Ching,Shen Chia I.,Luo Yung Hung,Chen Yuh Min,Chiu Chao Hua,Chou Teh Ying,Chiang Chi Lu,Ho Hsiang Ling,Yeh Yi Chen,Lee Cheng Chia,Huang Hsu Ching,Shen Chia I.,Luo Yung Hung,Chen Yuh Min,Chiu Chao Hua,Chou Teh Ying. Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis . Journal of Cancer Research and Clinical Oncology .2023 ;(149):5-14

3. 2023 Che Ting Fang,Chiu Chao Hua,Wu Yu Chung,Chen Jia Yang,Chou Teh Ying,Cheng Yi Chun,Chiang Chi Lu,Huang Chien Sheng,Tuang I. Shuan,Ho Yang Hui,Hong Jian Hua,Huang Yen Jang,Ho Hsiang Ling,Chang Ying Chih,Che Ting Fang,Chiu Chao Hua,Wu Yu Chung,Chen Jia Yang,Chou Teh Ying,Cheng Yi Chun,Chiang Chi Lu,Huang Chien Sheng,Tuang I. Shuan,Ho Yang Hui,Hong Jian Hua,Huang Yen Jang,Ho Hsiang Ling,Chang Ying Chih. Proliferative ability of circulating tumor cells is a prognostic factor in Early-Stage lung adenocarcinoma . Lung Cancer .2023 ;(178):198-205

4. 2023 Chang GC,Chiu CH,Yu CJ,Chang YC,Chang YH,Hsu KH, Wu YC, Chen CY, Hsu HH, Wu MT, Yang CT, Chong IW, Lin YC, Hsia TC, Lin MC, Su WC, Lin CB, Lee KY, Wei YF, Lan GY, Chan WP, Wang KL, Wu MH, Tsai HH, Chian CF, Lai RS, Shih JY, Wang CL, Hsu JS, Chen KC, Chen CK, Hsia JY, Peng CK, Tang EK, Hsu CL, Chou TY, Shen WC, Tsai YH, Tsai CM, Chen YM, Lee YC, Chen HY, Yu SL, Chen CJ, Wan YL, Hsiung CA, Yang PC; TALENT Investigators.. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study . Lancet Respir Med .2023

5. 2023 Chiu CH,Lin MC,Wei YF ,Chang GC,Su WC,Hsia TC, Su J, Wang AK, Jen MH, Puri T, Shih JY. Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY Study . Targeted Oncology .2023

6. 2023 Chiu CH,Yang PC. Never Say No to Never-Smokers . Journal of Thoracic Oncology .2023

7. 2022 Chang Chih Jung,Shen Chia I,Wu Ching Lan,Chiu Chao Hua. Pneumatosis intestinalis induced by targeted therapy . Postgraduate Medical Journal .2022 ;(98):10-10

8. 2022 Shen Chia I.,Chiang Chi Lu,Shiao Tsu Hui,Luo Yung Hung,Chao Heng Sheng,Huang Hsu Ching,Chiu Chao Hua,Shen Chia I.,Chiang Chi Lu,Shiao Tsu Hui,Luo Yung Hung,Chao Heng Sheng,Huang Hsu Ching,Chiu Chao Hua. Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer . Scientific Reports .2022 ;(12)

9. 2022 Chiang Chi Lu,Shen Chia I.,Huang Hsu Ching,Chang Han Jhih,Huang Yu Ting,Chiu Chao Hua,Chiang Chi Lu,Shen Chia I.,Huang Hsu Ching,Chang Han Jhih,Huang Yu Ting,Chiu Chao Hua. Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer . Frontiers in Oncology .2022 ;(12)

10. 2022 Yang Szu Chun,Yeh Yi Chen,Chen Yi Lin,Chiu Chao Hua,Yang Szu Chun,Yeh Yi Chen,Chen Yi Lin,Chiu Chao Hua. Economic Analysis of Exclusionary EGFR Test Versus Up-Front NGS for Lung Adenocarcinoma in High EGFR Mutation Prevalence Areas . JNCCN Journal of the National Comprehensive Cancer Network .2022 ;(20):774-782

11. 2021 Chiang Chi Lu,Huang Hsu Ching,Luo Yung Hung,Chiu Chao Hua,Chiang Chi Lu,Huang Hsu Ching,Luo Yung Hung,Chiu Chao Hua. Cerebrospinal fluid as a medium of liquid biopsy in the management of patients with non-small-cell lung cancer having central nervous system metastasis . Frontiers in Bioscience - Landmark .2021 ;(26):1679-1688

12. 2021 Chiang Chi Lu,Lee Cheng Chia,Huang Hsu Ching,Wu Chia Hung,Yeh Yi Chen,Shen Chia I.,Luo Yung Hung,Shiao Tsu Hui,Chang Han Jhih,Huang Yu Ting,Chen Yuh Min,Chou Teh Ying,Chiu Chao Hua,Chiang Chi Lu,Lee Cheng Chia,Huang Hsu Ching,Wu Chia Hung,Yeh Yi Chen,Shen Chia I.,Luo Yung Hung,Shiao Tsu Hui,Chang Han Jhih,Huang Yu Ting,Chen Yuh Min,Chou Teh Ying,Chiu Chao Hua. Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis . Targeted Oncology .2021 ;(16):207-214

13. 2021 Shen Chia I.,Yeh Yi Chen,Chiu Chao Hua. Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report . JTO Clinical and Research Reports .2021 ;(2)

14. 2021 Lin Yen Ting,Chiang Chi Lu,Hung Jen Yu,Lee Mei Hsuan,Su Wu Chou,Wu Shang Yin,Wei Yu Feng,Lee Kang Yun,Tseng Yen Han,Su Jian,Chung Hsin Pei,Lin Chih Bin,Ku Wen Hui,Chiang Tsai Shin,Chiu Chao Hua,Shih Jin Yuan,Lin Yen Ting,Chiang Chi Lu,Hung Jen Yu,Lee Mei Hsuan,Su Wu Chou,Wu Shang Yin,Wei Yu Feng,Lee Kang Yun,Tseng Yen Han,Su Jian,Chung Hsin Pei,Lin Chih Bin,Ku Wen Hui,Chiang Tsai Shin,Chiu Chao Hua,Shih Jin Yuan. Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing . European Journal of Cancer .2021 ;(156):1-11

15. 2020 Shen Chia I.,Ho Hsiang Ling,Yeh Yi Chen,Chiu Chao Hua,Chou Teh Ying,Shen Chia I.,Ho Hsiang Ling,Yeh Yi Chen,Chiu Chao Hua,Chou Teh Ying. Epidermal growth factor receptor mutations in non–small cell lung cancer undetected by high-sensitivity allele-specific real-time polymerase chain reaction–based assays . Journal of the Chinese Medical Association .2020 ;(83):345-349

16. 2020 Chiang Chi Lu,Huang Hsu Ching,Shen Chia I.,Luo Yung Hung,Chen Yuh Min,Chiu Chao Hua,Chiang Chi Lu,Huang Hsu Ching,Shen Chia I.,Luo Yung Hung,Chen Yuh Min,Chiu Chao Hua. Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI . Targeted Oncology .2020 ;(15):503-512

17. 2020 Chiang Chi Lu,Yeh Yi Chen,Chou Teh Ying,Chiu Chao Hua. Squamous cell carcinoma transformation after acquired resistance to osimertinib in a patient with lung adenocarcinoma harboring uncommon EGFR mutation . Journal of the Formosan Medical Association .2020 ;(119):1439-1441

18. 2019 Shen Chia I.,Huang Hsu Ching,Chiang Chi Lu,Luo Yung Hung,Shiao Tsu Hui,Chiu Chao Hua,Shen Chia I.,Huang Hsu Ching,Chiang Chi Lu,Luo Yung Hung,Shiao Tsu Hui,Chiu Chao Hua. Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy . Lung Cancer .2019 ;(138):52-57

研究計畫

計畫名稱
113 以液體活檢改善目前的低劑量電腦斷層肺癌篩檢計畫—癌症篩檢的精準醫學(2/3)
補助單位
國家科學及技術委員會
計畫名稱
113 正子斷層掃描影像在小型亞實質性肺腫瘤局部治療中的角色 – 第一期
補助單位
國家科學及技術委員會
計畫名稱
112 以液體活檢改善目前的低劑量電腦斷層肺癌篩檢計畫—癌症篩檢的精準醫學(1/3)
補助單位
國家科學及技術委員會
計畫名稱
111 新聘教師研究補助
補助單位
臺北醫學大學
計畫名稱
111 以自動化電腦斷層影像分析及病患臨床特徵建立肺癌侵犯性的預測模型
補助單位
國家科學及技術委員會